Skip to search formSkip to main contentSkip to account menu

Buprenorphine / Naloxone

Known as: Buprenorphine-Naloxone Drug Combination, Buprenorphine-Naloxone, Buprenorphine Naloxone Combination 
A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESIC with naloxone, a NARCOTIC ANTAGONIST to reduce the potential for… 
National Institutes of Health

Related topics

Related topics

13 relations

Broader (2)

Analgesics, OpioidNarcotic Antagonists
BuprenorphineBuprenorphine 2 MG / Naloxone 0.5 MG Sublingual TabletBuprenorphine 2.1 MG / Naloxone 0.3 MG Buccal FilmIn Blood

Narrower (1)

Suboxone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugs.
Malaria continues to be a difficult disease to eradicate largely because of the widespread populations it affects and the… 
Highly Cited
2008
Highly Cited
2008
Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs.
Pharmacokinetic analysis of buprenorphine administered to six healthy dogs via the oral transmucosal (OTM) route at doses of 20… 
Highly Cited
2005
Highly Cited
2005
Role of Intracellular Glutathione in Cell Sensitivity to the Apoptosis Induced by Tumor Necrosis Factor α–Related Apoptosis-Inducing Ligand/Anticancer Drug Combinations
Purpose: We have recently shown that combination of tumor necrosis factor α–related apoptosis-inducing ligand (TRAIL) with… 
2005
2005
Establishment of artemisinin combination therapy as first line treatment for combating malaria : Artemisia annua cultivation in India needed for providing sustainable supply chain of artemisinin
The Plasmodium falciparum malaria is responsible for about 500 million clinical attacks and one million deaths each year, mostly… 
Highly Cited
2003
Highly Cited
2003
Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru.
In the Amazon Basin of Peru, more than 50% of patients with uncomplicated Plasmodium falciparum malaria fail to respond to… 
Review
2003
Review
2003
Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence.
Highly Cited
2000
Highly Cited
2000
Virological and immunological effects of antioxidant treatment in patients with HIV infection
Intracellular oxidative stress in CD4+ lymphocytes due to disturbed glutathione homeostasis may lead to impaired lymphocyte… 
Highly Cited
1999
Highly Cited
1999
Migraine-Related Seizures in an Epileptic Population
A relationship between epilepsy and migraine has long been postulated, but the nature of this interaction is still debated. We… 
Highly Cited
1988
Highly Cited
1988
Dynorphin A inhibits and naloxone increases the electrically stimulated release of oxytocin but not vasopressin from the terminals of the neural lobe.
Oxytocin release from the rat neurohypophysis is under endogenous opioid inhibition. It has recently been established that… 
1978
1978
Antagonism of naloxone hyperalgesia by ethanol.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)